Trial Profile
Antiviral resistance mutations to lamivudine monotherapy in patients with chronic hepatitis B
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2015
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 31 Mar 2015 New trial record
- 01 Nov 2011 Recruitment is completed, according to result published in the Molecular Diagnosis & Therapy.